Skip to main content

Advertisement

Table 3 Group means and standard deviations for Joint Moments; Sig†, p < 0.005.

From: The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients

  PAD pre PAD post Control p-values (effect size)
(%BWxBH) mean S.D. mean S.D. mean S.D. pre/post pre/con post/con
ADMM -3.41 0.97 -3.05 0.82 -3.74 1.11 0.030 (0.40) 0.241 (0.32) 0.011 (0.72)
APMM 14.84 1.62 15.54 1.69 15.05 1.57 0.036 (0.42) 0.632 (0.13) 0.266 (0.30)
KFMM 2.00 1.64 1.97 2.04 1.73 1.34 0.912 (0.02) 0.494 (0.19) 0.602 (0.14)
KEMM -6.59 2.50 -6.61 2.30 -8.42 2.48 0.950 (0.01) 0.009 (0.74) 0.007 (0.76)
HFMM 8.67 3.23 8.21 3.10 11.09 2.40 0.371 (0.14) 0.003† (0.86) < 0.001† (1.04)
HEMM -8.27 2.31 -8.69 2.45 -10.28 2.70 0.160 (0.17) 0.005 (0.80) 0.027 (0.62)
  1. ADMM - Peak ankle dorsiflexion moment during early stance; APMM - Peak ankle plantarflexion moment during late stance; KFMM - Peak knee flexion moment during stance; KEMM - Peak knee extension moment during stance; HFMM - Peak hip flexion moment during late stance; HEMM - Peak hip extension moment during early stance.